Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Oct 21, 2020 10:25 AM - Oct 22, 2020 4:15 PM

(US Eastern Standard Time)

Fort Washington, PA 19034

Canadian Pharmacovigilance and Risk Management Conference

Session 7: Pharmacovigilance of Cannabis and Related Products

Session Chair(s)

Marc  Poitras, PhD, MBA

Marc Poitras, PhD, MBA

Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau

Health Canada, Canada

Since the legalization of medical/recreational cannabis products, there has been a constant increase of adverse event cannabis related reporting to Health Canada. On June 30th, 2020, Health Canada issued its Guidance to Industry regarding Cannabis Adverse Reaction Reporting. In this session, representatives from Health Canada, and the Industry will discuss the specific aspects of Cannabis Pharmacovigilance focusing on the implementation of the new Guidance and will address questions/challenges stemming from the experience thus far in relation to the application of the Guidelines.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand the Guidance to Industry Regarding Cannabis Adverse Reaction Reporting
  • Develop Procedures to Enable your Company to React Appropriately to Reports of Adverse Reactions, Including the Activities of Monitoring, Reporting, Assessing, and Understanding their Nature in Order to Minimize Preventable Harms Associated with Cannabis Use

Speaker(s)

Robert  Pawinski, MEd, MHA, MSN

Speaker

Robert Pawinski, MEd, MHA, MSN

R&R Executive Consulting, United Kingdom

Chief Medical Officer

Stephanie  Jack, MSc

Speaker

Stephanie Jack, MSc

Health Canada, Canada

Scientific Manager

Chanez Narimene  Kebache, MBA

Speaker

Chanez Narimene Kebache, MBA

Canopy Growth Corporation, Canada

Director, Global Product Safety & Pharmacovigilance

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.